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occidioides brasiliensis, which in their saprophytic mold
orm and under certain environmental conditions produce
icroconidia (< 5m). These propagules become air-born
nd are accidentally inhaled by man; once in the lungs
hey convert to the tissue e forms. Most patients are adult
ales engaged in aerosol-generating activities (agriculture,
orestry, masonry, speleology), with women and children
eing afﬂicted less often. The three mycoses initiate their
athologic expression in the lungs but extra-pulmonary dis-
emination is common mainly to mucous membranes, skin,
ymph nodes, liver, spleen, adrenals, bones, CNS and oth-
rs; these entities are systemic and one-organ affection
s rare. Signs and symptoms may be related to the res-
iratory tract but are more often referred to secondary
esions making it difﬁcult to conﬁrm suspicion on clinical evi-
ence alone. Image studies vary depending on the diseases’
ourse and include inﬁltrates, nodules, cavities, pleural
etraction, ﬁbrosis and calciﬁcations. Deﬁnitive diagnosis
s established only on mycological grounds through biop-
ies, direct examinations and cultures. The three etiologic
gents’ differential characteristics under the microscope
lus the type of propagules produced in cultures, allow
heir precise identiﬁcation. Availability of several indirect
ests to determine circulating antibodies and antigens and
lso of several DNA-based tests serve to conﬁrm diagnosis
nd facilitate follow-up studies. These mycoses are difﬁ-
ult to treat requiring prolonged courses and careful medical
upervision. Treatment has greatly improvedwith the advent
f the new triazoles (itraconazole, voriconazole, posacona-
ole) but amphotericin B remains a major therapy; recovery
s contingent on prompt diagnosis, patient’s immune status
nd stage of the mycosis at therapy initiation.
oi:10.1016/j.ijid.2010.02.1523
5.003
ungal Skin Infections in the Tropics
. Hay
International Foundation of Dermatology, London, United
ingdom
The main challenges confronting us in the tropical
ycoses are 1) rapid and accurate diagnosis 2) the avail-
bility of appropriate therapy and 3) a rising incidence of
ertain infections. Diagnosis is dependent on the logical
ssociation between the clinical appearances and appropri-
te laboratory steps. However key features of fungi that aid
heir recognition are their size and the simple cultural and
istological techniques used to detect them. Use of con-
entional histopathology or immunopathological techniques
s highly effective in many cases but molecular tools are
ow used for some conditions including dermatophytosis and
porotrichosis. With some mycoses the process is simpler. In
ycetomas, for instance, histological or cultural evidence
an be obtained directly from sinuses or by biopsy.
Most new antifungals have not been proﬁled with trop-
cal mycoses in mind and there are few evidence-based
linical trials to establish usage or duration of therapy.
he commonest of these infections that present major
herapeutic problems are the mycetomas and chromoblasto-
ycosis. Fungal mycetomas seldom respond to normal doses
v
u
i
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f antifungals; whereas those caused by bacteria, actino-
ycetomas, respond to a range of antibacterials such as
apsone, amikacin, fusidic acid, imipenem etc unless they
re very extensive. There is only limited reporting of the
se of newer azoles, posaconazole and voriconazole in these
ycoses. Mycoses where there have been changes in epi-
emiology, suggesting, spread include tinea capitis. Spread
f Trichophyton tonsurans infections to South America and
est Africa are examples. Whereas HIV in many countries
s controlled through the use of antiretrovirals in infected
ndividuals late recognition is a feature in many areas of
he tropics and therefore there is a continuing risk of sys-
emic fungal infections presenting with skin lesions as their
rst and most obvious clinical manifestation. Being alert to
hese changes provides a rapid means of dealing with these
nfections.
oi:10.1016/j.ijid.2010.02.1524
5.004
revention and Treatment of Nosocomial Candidiasis
. Nucci
University Fed. Rio de Janeiro, Rio de Janeiro, Brazil
Candidemia is an important nosocomial infection, with
igh incidence and mortality rates. Strategies for the man-
gement of candidemia include prophylaxis and treatment
f established infection. Prophylaxis is more likely to ben-
ﬁt groups of patients with high incidence of candidemia,
uch as premature neonates, allogeneic hematopoietic stem
ell transplant recipients and high-risk liver transplant
ecipients. For the treatment of candidemia, various stud-
es have been conducted comparing different drugs, such
s ﬂuconazole, voriconazole, deoxycholate and liposomal
mphotericin B, and the echinocandins caspofungin, mica-
ungin and anidulafungin. In general, the echinocandins
epresent the best option for the initial treatment of can-
idemia. In addition to prophylaxis and treatment, attempts
o deﬁne a group of patients that may beneﬁt from early
mpiric or preemptive have been developed. These include
he development of prediction rules and the use of serum
iomarkers such as 1,3-beta-D-glucan and polymerase chain
eaction-base techniques.
oi:10.1016/j.ijid.2010.02.1525
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6.001
he Changing Patterns of Global Migration and the Impact
n Infectious Diseases
. Cetron
CDC, Atlanta, GA, USA
Human migration has always been associated with dis-
ase translocation. Over the last century the speed and
olume of international travel and migration has reached
nprecedented levels bringing the impact of globalization
nto every sector of society- economic, environmental,
olitical, socio-cultural, and health. As a consequence, the
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threat of geographic expansion from emerging and tradi-
tional infectious diseases has increased. UNESCO deﬁnes
an international migrant as a person living outside their
birth country for >= 12 months. The global patterns of
human migration have changed substantially in the last
half century: 1) increased # countries sending and receiving
migrants, 2) accelerated rates of migration, 3) bi-directional
migration and migration transitions, 4) diversiﬁcation of
migrant types, and 5) changes in gender patterns of
migrants. Along with these profound changes in demography,
volume, speed, and purpose of migration come unique chal-
lenges in detection, diagnosis, response and management
of infectious diseases. Even in the 21st Century infectious
diseases account for ∼25% of the global mortality burden
as well as substantial morbidity. Increasingly these diseases
are blind to geopolitical borders. Cyclical pandemics like
inﬂuenza traverse the globe more rapidly than ever; newly
emerged pathogens like SARS represent a constant challenge
to public health preparedness and response. Even old dis-
eases like tuberculosis emerge in more lethal drugresistant
forms e.g. XDR-TB. These challenges demand new paradigms
to global disease control in governance, surveillance and
response. The 2005 International Health Regulations and a
range of newly formed international networks and partner-
ships are a testament to the challenges posed by the new
era of migration. Our success in combating these microbial
threats will depend on our collective effort to organize and
respond on ‘‘supra national’’ level.
doi:10.1016/j.ijid.2010.02.1526
Will the next generation end AIDS? (Invited Presen-
tation)
17.001
Role of innate immunity in the control of HIV infection
G. Alter
MGH, Boston, USA
While the immunological correlates that contribute to
slower HIV disease progression are still unknown, epi-
demiologic data strongly suggest that particular major
histocompatibility complex (MHC) class 1 alleles (including
-B27, -B57, and others that fall within the HLA-Bw4 fam-
ily of HLA-class I B alleles) are highly enriched in subjects
who maintain undetectable viral loads in the absence of
antiretroviral therapy, Elite controllers. While these MHC
molecules interact with T-cell receptors found on cytotoxic
CD8+ T cells, they also interact with innate immune recep-
tors, such as the Killer Immunoglobulin like receptors (KIR)
found on the surface of innate cytotoxic Natural Killer (NK)
cells. Furthermore, the protective effect of MHC class I alle-
les is ampliﬁed in subjects that co-express particular KIRs,
with which they are able to interact, resulting in slower pro-
gression to AIDS in these individuals compared to those that
only possess the KIR or MHC allele alone. Thus it is plausible
that NK cells may play a central role in the control of HIV
infection. NK cells expand rapidly following acute infection,
and speciﬁc populations of KIR+ NK cells expand preferen-
tially in subjects that co-express protective KIR/MHC class 1
combinations. This speciﬁc KIR3DS1+ NK cell clonal expan-
t
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ion persists for up to 1 year in the peripheral circulation,
nd is associated with more aggressive containment of HIV-
iral replication in vitro, these NK cells exhibit a more
olyfunctional cytokine proﬁle, and kill MHC class 1 target
ells more more aggressively than NK cells from individuals
hat do not have the protective KIR/HLA combined geno-
ype. However, despite this early epansion of NK cells in the
eriphery, these cells do not gain access to secondary lym-
hoid organs, thus providing a safe haven within which the
irus is able to replicate unabated by the innate immune
ystem, potentially allowing the virus to establish a chronic
nfection. These data strongly suggest durable control of HIV
nfection is associated with an early aggressive deployment
f highly licensed antiviral NK cells in the periphery that
ay provide speciﬁc and non-speciﬁc control of HIV viral
eplication in acute infection, while producing large quanti-
ies of cytokines and chemokines required for the induction
f high quality adaptive immune responses that may then
aintain control of HIV replication most likely in contained
issue sites.
oi:10.1016/j.ijid.2010.02.1527
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he Role of T Cell Immunity in the Control of HIV Infection
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oore1, H. Yang7, B. Keele4, P. Borrow1, M. Cohen8, A.
erelson3, F. Gao6, B. Hahn4, G. Shaw4, B.T. Korber3, A.J.
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The window between transmission and peak viremia,
rior to the establishment of viral reservoirs, is the narrow
ut critical period in which a HIV-1 vaccine must control
iral replication, prevent extensive CD4 T cell destruction
nd curb generalised immune activation. We recently pub-
ished the results of T cell studies in 4 patients, showing that
he ﬁrst HIV-1 speciﬁc T cells detectable just prior to peak
iremia can select for complete virus escape in as little as
4 days.
Mathematical modeling of these very rapid rates of T cell
scape showed that the contribution of CD8+ T cell mediated
illing of productively infected cells was earlier and signif-
cantly greater than previously described; calculating that
cells in acute HIV-1 kill as much as 35% of virus-infected
ells per day. These ﬁrst T cell responses often waned rapidly
ollowing virus escape leaving, or being succeeded by, T cell
esponses to epitopes that escaped slowly or were invari-
nt. Here, we present data from an additional 10 patients
hat extend these observations and demonstrate that early
apid escape from primary HIV-1-speciﬁc T cell responses
ccurs in the majority of patients studied, suggesting that
cells are major contributors to the control of viremia in
